Q&A with Karin de Visser.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 41260201.
- Also identified by DOI 10.1016/j.xcrm.2025.102457.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Karin de Visser is senior group leader at the Division of Tumor Biology & Immunology at the Netherlands Cancer Institute. In this interview with Cell Reports Medicine, Karin de Visser talks about her journey in science and shares her insights about tumor microenvironment modulation to improve patient therapies.
Medical subject headings
- Tumor Microenvironment
- Neoplasms